Literature DB >> 2358628

An outbreak of an influenza-like illness in a nursing home.

D Osterweil1, D Norman.   

Abstract

As part of an ongoing infection surveillance program, data were collected on an outbreak of respiratory illness affecting 29% of residents in a 231-bed long-term care facility. Viral titers could be collected on 60% of the ill residents and respiratory syncytial virus (RSV) was established in 14 of the symptomatic patients and was thought to be the probable cause of the outbreak. Compared with previously reported long-term institutional outbreaks of RSV, there were significantly fewer cases of pneumonia (5% vs. 14% to 55%) and deaths (2% vs. 6% to 20%). However, morbidity was substantial in this outbreak, with 46% of patients suffering prolonged malaise and anorexia; the mean duration of symptoms was four weeks. Respiratory syncytial virus may be an important cause of respiratory illness in nursing homes and may be unappreciated if specific diagnostic methods are not employed. The recent availability of rapid diagnostic tests and specific antiviral therapy for RSV warrant further clinical studies to develop management strategies for this infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358628     DOI: 10.1111/j.1532-5415.1990.tb01425.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  15 in total

Review 1.  Medical care of the elderly in the nursing home.

Authors:  P Starer; L S Libow
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

2.  Baculovirus expression of the respiratory syncytial virus fusion protein using Trichoplusia ni insect cells.

Authors:  M Parrington; S Cockle; P Wyde; R P Du; E Snell; W Y Yan; Q Wang; L Gisonni; S Sanhueza; M Ewasyshyn; M Klein
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

3.  Respiratory syncytial virus infection in older adults: an under-recognized problem.

Authors:  Angela R Branche; Ann R Falsey
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

Review 4.  Respiratory syncytial virus infection in adults.

Authors:  A R Falsey; E E Walsh
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 5.  Respiratory syncytial virus infection in the elderly.

Authors:  G Mlinaric-Galinovic; A R Falsey; E E Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

6.  Overcoming T cell-mediated immunopathology to achieve safe RSV vaccination.

Authors:  Elaine M Castilow; Steven M Varga
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

7.  The prediction of epidemics of respiratory infection.

Authors:  D M Fleming
Journal:  Eur J Epidemiol       Date:  1994-08       Impact factor: 8.082

8.  Orally active fusion inhibitor of respiratory syncytial virus.

Authors:  Christopher Cianci; Kuo-Long Yu; Keith Combrink; Ny Sin; Bradley Pearce; Alan Wang; Rita Civiello; Stacey Voss; Guangxiang Luo; Kathy Kadow; Eugene V Genovesi; Brian Venables; Hatice Gulgeze; Ashok Trehan; Jennifer James; Lucinda Lamb; Ivette Medina; Julia Roach; Zheng Yang; Lisa Zadjura; Richard Colonno; Junius Clark; Nicholas Meanwell; Mark Krystal
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

Review 9.  Respiratory viral infections in the elderly.

Authors:  J Treanor; A Falsey
Journal:  Antiviral Res       Date:  1999-12-15       Impact factor: 5.970

Review 10.  Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Authors:  Elaine M Castilow; Matthew R Olson; Steven M Varga
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.